Syndax Pharmaceuticals Inc - SNDX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$2.394B
QoQ value delta ($000)
+$48.97M (+2.09%)
Implied price effect (QoQ)
-6.24%
Shares
Total shares
109,502,398
QoQ shares delta
+8,933,503 (+8.88%)
Total shares held by funds (by quarter)

Market chart (SNDX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 244 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
BlackRock, Inc. 197,177 9,020,006 0.0%
Kynam Capital Management, LP 175,993 8,050,959 9.73%
GOLDMAN SACHS GROUP INC 128,127 5,861,265 0.01%
STATE STREET CORP 123,693 5,658,424 0.0%
BANK OF AMERICA CORP /DE/ 88,425 4,045,094 0.01%
VANGUARD CAPITAL MANAGEMENT LLC 85,863 3,927,892 0.0%
DEERFIELD MANAGEMENT COMPANY, L.P. 82,628 3,779,900 0.86%
Eversept Partners, LP 61,168 2,798,210 3.17%
GEODE CAPITAL MANAGEMENT, LLC 56,499 2,584,136 0.0%
Hood River Capital Management LLC 56,055 2,564,279 0.41%
KINGDON CAPITAL MANAGEMENT, L.L.C. 54,650 2,500,000 5.6%
FRANKLIN RESOURCES INC 49,982 2,286,499 0.01%
MILLENNIUM MANAGEMENT LLC 44,899 2,053,960 0.02%
VANGUARD PORTFOLIO MANAGEMENT LLC 42,010 1,921,796 0.0%
SILVERARC CAPITAL MANAGEMENT, LLC 41,708 1,907,990 4.33%
UBS Group AG 41,397 1,893,750 0.01%
Elmind Capital, LP 40,550 1,855,000 10.19%
BNP Paribas Asset Management Holding S.A. 39,133 1,790,173 0.04%
Candriam S.C.A. 37,039 1,696,040 0.17%
Soleus Capital Management, L.P. 35,588 1,628,039 1.23%
TWO SIGMA INVESTMENTS, LP 34,497 1,578,125 0.02%
ORBIMED ADVISORS LLC 33,708 1,542,000 0.62%
Nuveen, LLC 29,829 1,364,575 0.01%
MPM BioImpact LLC 29,150 1,333,523 1.78%
Aisling Capital Management LP 28,785 1,316,806 6.1%